H. Bel Abed et al. / Tetrahedron Letters 53 (2012) 6489–6491
6491
Organicheskoi Khimii 2008, 44, 1840–1843; (l) Supurgibekov, M. B.; Yanyuk, N.
S.; Nikolaev, V. A. Zhurnal Organicheskoi Khimii 2011, 47, 1252–1255.
2. (a) Benson, S. C.; Palabrica, C. A.; Snyder, J. K. J. Org. Chem. 1987, 52, 4610–4614;
(b) Rohet, F.; Rubat, C.; Coudert, P.; Couquelet, J. Bioorg. Med. Chem. Lett. 1997,
5, 655–659; (c) Tucker, J. A.; Allwine, D. A.; Grega, K. C.; Barbachyn, M. R.; Klock,
J. L.; Adamski, J. L.; Brickner, S. J.; Hutchinson, D. K.; Ford, C. W.; Zurenko, G. E.;
Conradi, R. A.; Burton, P. S.; Jensen, R. M. J. Med. Chem. 1998, 41, 3723–3735; (d)
Gyoten, M.; Nagaya, H.; Fukuda, S.; Ashida, Y.; Kawano, Y. Chem. Pharm. Bull.
2003, 51, 122–133; (e) Tamayo, N.; Liao, L.; Goldberg, M.; Powers, D.; Tudor, Y.
Y.; Yu, V.; Wong, L. M.; Henkle, B.; Middleton, S.; Syed, R.; Harvey, T.; Jang, G.;
Hungate, R.; Dominguez, C. Bioorg. Med. Chem. Lett. 2005, 15, 2409–2413.
3. (a) Tisler, M.; Stanovnik, B. Adv. Heterocycl. Chem. 1990, 49, 385–474. and
references cited therein; (b) Joule, J. A.; Mills, K. Heterocyclic chemistry; Mir
Press: Moscow, Russia, 2004.
4. (a) Ellis, G. P. Synthesis of Fused Heterocycles; John Wiley and Sons Inc.: New
York, 1987. pp 226–239; (b) Naud, S.; Pipelier, M.; Viault, G.; Adjou, A.; Huet, F.;
Legoupy, S.; Aubertin, A. M.; Evain, M.; Dubreuil, D. Eur. J. Org. Chem. 2007,
3296–3310.
5. Okaniwa, M.; Hirose, M. M.; Imada, T.; Ohashi, T.; Hayashi, Y.; Miyazaki, T.;
Arita, T.; Yabuki, M.; Kakoi, K.; Kato, J.; Takagi, T.; Kawamoto, T.; Yao, S.;
Sumita, A.; Tsutsumi, S.; Tottori, T.; Oki, H.; Sang, B.; Yano, J.; Aertgeerts, K.;
Yoshida, S.; Ishikawa, T. J. Med. Chem. 2012, 55, 3452–3478.
6. Alberati, D.; Gobbi, L.; Koerner, M.; Kuhn, B.; Peters, J.; Rodriguez Sarmiento, R.
M.; Roger-Evans, M.; Rudolph, M. Patent WO2010/063610.
7. Blackaby, W.; Blurton, P.; Burkamp, F.; Fletcher, S.; Jennings, A.; Lewis, R.;
Macleod, A.; Street, L.; Thomas, S.; Vanniel, M.; Wilson, K. Patent WO2004/
014865.
8. (a) Zelesov, V. V. et al Zhurnal Organicheskoi Khimii 1995, 32, 735–740; (b) Aliev,
Z. G.; Vyaznikova, N. G.; Zalesov, V. V.; Kataev, S. S.; Andreichikov, Y. S.;
Atovmyan, L. O. Russ. Chem. Bull. 1997, 46, 2142–2145.
9. Xie, L.; Han, B.; Xu, Y.; Maynard, G. Patent WO2004/031174.
10. (a) Huckin, S.; Weiler, L. Tetrahedron Lett. 1971, 50, 4835–4838; (b) Huckin, S.;
Weiler, L. Can. J. Chem. 1974, 52, 2157–2164.
11. Clarke, P. A.; Martin, W. H. C.; Hargreaves, J. M.; Wilson, C.; Blake, A. J. Org.
Biomol. Chem. 2005, 3, 3551–3563.
12. (a) Regitz, M.; Maas, G. Diazo Compounds Properties and Synthesis; Academic
Press: London, 1986. pp 65–198; (b) Padwa, A.; Weingarten, M. D. Chem. Rev.
1996, 96, 223–269; (c) Doyle, M. P.; McKervey, M. A.; Ye, T. Modern Catalytic
Methods for Organic Synthesis with Diazo Compounds; Wiley: New York, 1998;
(d) Davies, H. M. L.; Beckwith, R. E. J. Chem. Rev. 2003, 103, 2861–2903; (e)
Zhang, Z.; Wang, J. Tetrahedron 2008, 64, 6577–6605; For a recent review on
the synthesis of diazo compounds, see: (f) Maas, G. Angew. Chem., Int. Ed. 2009,
48, 8186–8195; For selected reports on remote functionalized diazo
compounds, see: (g) Xu, X.; Hu, W.-H.; Doyle, M. P. Angew. Chem., Int. Ed.
2011, 50, 6392–6395; (h) Zhou, L.; Doyle, M. P. Org. Lett. 2010, 12, 796–799; (i)
Yu, L.; Zhang, Y.; Jee, N.; Doyle, M. P. Org. Lett. 2008, 10, 1605–1608; (j) Doyle,
M. P.; Kundu, K.; Russell, A. E. Org. Lett. 2005, 7, 5171–5174; (k) Deng, G.; Tian,
X.; Qu, Z.; Wang, J. Angew. Chem., Int. Ed. 2002, 41, 2773–2776; (l) Liao, M.;
Dong, S.; Deng, G.; Wang, J. Tetrahedron Lett. 2006, 47, 4537–4540; (m) Zhao,
Y.; Wang, J. Synlett 2005, 2886–2892; (n) Dong, C.; Mo, F.; Wang, J. J. Org. Chem.
2008, 73, 1971–1974; (o) Dong, C.; Deng, G.; Wang, J. J. Org. Chem. 2006, 71,
5560–5564; (p) Padwa, A.; Zhang, Z. J.; Zhi, L. J. Org. Chem. 2000, 65, 5223–
5232.
13. Frigerio, M.; Santagostino, M.; Sputore, S. J. Org. Chem. 1999, 64, 4537–4538.
14. Typical procedure for 9e: To a solution of 7e (7.24 mmol, 1.0 equiv) in 20 mL of
dichloromethane was added 1.32 mL of HMPT (hexamethylphosphorous
triamide) (7.24 mmol, 1.0 equiv). The mixture was then stirred at room
temperature overnight. After completion of the reaction (TLC), the reaction
mixture was quenched with the addition of water. The organic phase was then
washed several times with water, dried over Na2SO4, and concentrated in
vacuo. Flash column chromatography on silica gel (ethyl acetate/methanol
90:10) afforded the desired product 9e as an orange powder (850 mg, 45%). 1
H
NMR (500 MHz, DMSO-d6) 7.77 (d, J = 8.8 Hz, 2H), 7.12 (d, J = 8.8 Hz, 2H), 6.81
(s, 1H), 3.84 (s, 6H). 13C NMR (125 MHz, DMSO-d6) 164.2, 161.7, 148.2, 129.0,
122.8, 115.0, 114.7, 55.6, 52.5. HRMS Calculated for C13H12N2O4 261.0831,
Found 261.0871.